KL
KARINA LYNCH
WILLIAMS AND JENSEN, PLLC · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
In the field
2 yrs
registered since 2024
Clients
23
last 3 years
Filings
58
11 agencies contacted
Activity
filings by quarter
Works on
Health Issues 45Medicare/Medicaid 36Budget/Appropriations 22Taxation/Internal Revenue Code 16Defense 13Trade (domestic/foreign) 13Copyright/Patent/Trademark 6Medical/Disease Research/Clinical Labs 6Homeland Security 4Labor Issues/Antitrust/Workplace 4Aviation/Airlines/Airports 4Transportation 3Financial Institutions/Investments/Securities 3Law Enforcement/Crime/Criminal Justice 3Education 2Agriculture 2Environment/Superfund 2Alcohol and Drug Abuse 1Consumer Issues/Safety/Products 1Media (information/publishing) 1Communications/Broadcasting/Radio/TV 1
Background
Career
WJ
Government experience
Staff
Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committees on Aging and Gov. Affairs
Disclosed on LD-2 filings
Staff
Senate Special Committee on Aging; Staff, Senate Committee on Government Affairs; Senate Committee on Aging and Gov Affairs
Disclosed on LD-2 filings
Specific issues
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Implementation of P.L. 117-169 provisions related to Medicare prescription drugs.
General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Pharmacy benefit manager reform proposals.
Policies impacting vaccine access, disease prevention programs, and prescription drug labeling requirements.
General education about policies impacting pharmaceutical development, approval and reimbursement; Drug safety and drug counterfeiting; Medicare Part D; drug importation; and drug shortages. Drug pricing proposals. Medicare rebate reform, the 340B program, and proposals to impose "most favored nation" pricing on Medicare Part B and D. "Inflation Reduction Act of 2022" (PL 117-169). PASTEUR Act. Policies impacting post pandemic public health emergency Covid-19 vaccine reimbursement and distribution. Pharmacy benefit manager reform proposals. Public Law 118-47.
Issues related to pharmaceutical manufacturing and development.
Issues related to pharmaceutical manufacturing and development. Legislative proposals related to WTO TRIPS Waiver.
Clients
Filing history
PFIZER
AMERICAN AIRLINES, INC.
AMGEN, INC.
PLASMA PROTEIN THERAPEUTICS ASSOCIATION
NOVO NORDISK INC.
ELI LILLY & COMPANY
PHRMA
SANOFI, U.S.
WISCONSIN PHYSICIANS SERVICE INSURANCE CORPORATION (DBA WPS HEALTH SOLUTIONS)
IOWA CONFLUENCE WATER TRAILS (FORMERLY CENTRAL IOWA WATER TRAILS)
IRHYTHM TECHNOLOGIES
NATIONAL ASSOCIATION OF REHABILITATION PROVIDERS AND AGENCIES